19-16482507-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_145046.5(CALR3):​c.861G>A​(p.Thr287Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 1,614,202 control chromosomes in the GnomAD database, including 212 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 15 hom., cov: 33)
Exomes 𝑓: 0.015 ( 197 hom. )

Consequence

CALR3
NM_145046.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -7.85
Variant links:
Genes affected
CALR3 (HGNC:20407): (calreticulin 3) The protein encoded by this gene belongs to the calreticulin family, members of which are calcium-binding chaperones localized mainly in the endoplasmic reticulum. This protein is also localized to the endoplasmic reticulum lumen, however, its capacity for calcium-binding may be absent or much lower than other family members. This gene is specifically expressed in the testis, and may be required for sperm fertility. Mutation in this gene has been associated with familial hypertrophic cardiomyopathy. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-16482507-C-T is Benign according to our data. Variant chr19-16482507-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 220787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-16482507-C-T is described in Lovd as [Benign]. Variant chr19-16482507-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-7.85 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0117 (1775/152328) while in subpopulation NFE AF= 0.016 (1091/68034). AF 95% confidence interval is 0.0152. There are 15 homozygotes in gnomad4. There are 951 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1775 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CALR3NM_145046.5 linkc.861G>A p.Thr287Thr synonymous_variant Exon 7 of 9 ENST00000269881.8 NP_659483.2 Q96L12A0A140VJF7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CALR3ENST00000269881.8 linkc.861G>A p.Thr287Thr synonymous_variant Exon 7 of 9 1 NM_145046.5 ENSP00000269881.3 Q96L12
ENSG00000141979ENST00000409035.1 linkn.*664G>A non_coding_transcript_exon_variant Exon 10 of 12 2 ENSP00000386951.2 B8ZZF3
ENSG00000141979ENST00000409035.1 linkn.*664G>A 3_prime_UTR_variant Exon 10 of 12 2 ENSP00000386951.2 B8ZZF3
CALR3ENST00000602234.1 linkn.535G>A non_coding_transcript_exon_variant Exon 3 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.0116
AC:
1772
AN:
152210
Hom.:
15
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00251
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.0136
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00911
Gnomad FIN
AF:
0.0392
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0160
Gnomad OTH
AF:
0.00812
GnomAD3 exomes
AF:
0.0122
AC:
3060
AN:
251488
Hom.:
38
AF XY:
0.0123
AC XY:
1674
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00286
Gnomad ASJ exome
AF:
0.0112
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00869
Gnomad FIN exome
AF:
0.0361
Gnomad NFE exome
AF:
0.0150
Gnomad OTH exome
AF:
0.0109
GnomAD4 exome
AF:
0.0148
AC:
21571
AN:
1461874
Hom.:
197
Cov.:
45
AF XY:
0.0147
AC XY:
10726
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.00122
Gnomad4 AMR exome
AF:
0.00291
Gnomad4 ASJ exome
AF:
0.0104
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00949
Gnomad4 FIN exome
AF:
0.0371
Gnomad4 NFE exome
AF:
0.0158
Gnomad4 OTH exome
AF:
0.0112
GnomAD4 genome
AF:
0.0117
AC:
1775
AN:
152328
Hom.:
15
Cov.:
33
AF XY:
0.0128
AC XY:
951
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.00250
Gnomad4 AMR
AF:
0.00314
Gnomad4 ASJ
AF:
0.0136
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00974
Gnomad4 FIN
AF:
0.0392
Gnomad4 NFE
AF:
0.0160
Gnomad4 OTH
AF:
0.00803
Alfa
AF:
0.0125
Hom.:
5
Bravo
AF:
0.00823
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.0150
EpiControl
AF:
0.0133

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypertrophic cardiomyopathy 19 Benign:3
Jun 28, 2017
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
Aug 17, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: The CALR3 c.861G>A (p.Thr287Thr) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a benign outcome for this variant. 3/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may not abrogate existing or create new ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 1523/121410 control chromosomes (18 homozygotes) from ExAC at a frequency of 0.0125443, which is approximately 502 times the estimated maximal expected allele frequency of a pathogenic CALR3 variant (0.000025), suggesting this variant is likely a benign polymorphism. One clinical diagnostic laboratory in ClinVar has classified this variant as benign. To our knowledge, this variant has not been reported in affected individuals in literature. Taken together, this variant is classified as benign. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 23, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Cardiovascular phenotype Benign:1
Feb 15, 2013
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.052
DANN
Benign
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs118131979; hg19: chr19-16593318; API